Engineers Gate Manager’s Assembly Biosciences ASMB Stock Holding History

Engineers Gate Manager’s Portfolio ASMB Stock Details ASMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$261K	Sell	9,423 -952	-9%	-$27.2K	﹤0.01%	1777
2025 Q4	$353K	Buy	+10,375	New	+$334K	﹤0.01%	1544
2024 Q1	–	Sell	-839	Closed	-$8.26K	–	1902
2023 Q4	$8.26K	Hold	839	–	–	﹤0.01%	1926
2023 Q3	$8.91K	Hold	839	–	–	﹤0.01%	1729
2023 Q2	$11.6K	Buy	+839	New	+$10.3K	﹤0.01%	1681
2022 Q3	–	Sell	-1,595	Closed	-$40K	–	1602
2022 Q2	$40K	Buy	+1,595	New	+$36.7K	﹤0.01%	1800
2021 Q3	–	Sell	-2,650	Closed	-$123K	–	1627
2021 Q2	$123K	Sell	2,650 -4,535	-63%	-$225K	0.01%	1474
2021 Q1	$397K	Sell	7,185 -3,004	-29%	-$199K	0.02%	1141
2020 Q4	$740K	Buy	10,189 +8,918	+702%	+$1.05M	0.03%	738
2020 Q3	$251K	Buy	1,271 +432	+51%	+$109K	0.01%	1334
2020 Q2	$235K	Buy	+839	New	+$196K	0.01%	1351
2019 Q3	–	Sell	-1,997	Closed	-$323K	–	1369
2019 Q2	$323K	Sell	1,997 -1,585	-44%	-$301K	0.02%	851
2019 Q1	$846K	Buy	3,582 +1,962	+121%	+$497K	0.05%	485
2018 Q4	$440K	Sell	1,620 -295	-15%	-$85.3K	0.04%	555
2018 Q3	$853K	Buy	1,915 +711	+59%	+$333K	0.07%	382
2018 Q2	$567K	Buy	+1,204	New	+$637K	0.04%	514

Other funds holding ASMB

Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PHP

Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Engineers Gate Manager's ASMB Position: Q1 2026 in Review

Engineers Gate Manager reduced its Assembly Biosciences (ASMB) stake by 9.2% in Q1 2026, selling an estimated $27.2K and leaving 9,423 shares worth $261K. The position accounts for ﹤0.01% of the portfolio, ranked #1777.

Engineers Gate Manager first reported a position in ASMB in Q2 2018 and has held it in 16 quarters since. The position peaked at $853K in Q3 2018. 75 funds tracked by Wall St. Rank hold ASMB as of Q1 2026.

Engineers Gate Manager held 9,423 shares of Assembly Biosciences worth $261K as of Q1 2026.
Engineers Gate Manager sold 952 Assembly Biosciences shares in Q1 2026, an estimated $27.2K.
Assembly Biosciences made up ﹤0.01% of Engineers Gate Manager's portfolio in Q1 2026, its #1777 holding.
Engineers Gate Manager first reported a position in Assembly Biosciences in Q2 2018 and has held it in 16 quarters since.
Engineers Gate Manager's Assembly Biosciences position peaked at $853K in Q3 2018.
75 funds tracked by Wall St. Rank held Assembly Biosciences as of Q1 2026.

Based on Engineers Gate Manager's 13F filing for Q1 2026, filed 15 May 2026.